Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;235(10):6393-6403.
doi: 10.1002/jcp.29639. Epub 2020 Mar 20.

Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events

Reza Jafarzadeh-Esfehani  1 , Seyed Mostafa Parizadeh  2   3 , Amirsaeed Sabeti Aghabozorgi  4 , Negar Yavari  3 , Ariane Sadr-Nabavi  1 , Seyed Alireza Parizadeh  2 , Maryam Ghandehari  2   3 , Afsane Javanbakht  2   3 , Afsaneh Rezaei-Kalat  5 , Seyed Mahdi Hassanian  2 , Mohammad Vojdanparast  6 , Gordon A Ferns  7 , Majid Khazaei  2   3 , Amir Avan  2   3
Affiliations
Review

Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events

Reza Jafarzadeh-Esfehani et al. J Cell Physiol. 2020 Oct.

Abstract

Venous and arterial thrombosis are conditions that have a considerable burden if left untreated. The hypoxia-induced by the occluded vessel can disrupt the circulation of any organ, the cornerstone of treating thrombosis is rapid diagnosis and appropriate treatment. Diagnosis of thrombosis may be made by using laboratory tests or imaging techniques in individuals who have clinical manifestations of a thrombotic event. The use of serum micro ribonucleic acids (RNAs) has recently been applied to the diagnosis of thrombosis. These small RNA molecules are emerging as new diagnostic markers but have had very limited applications in vascular disease. Most of the articles provided various microRNAs with different levels of accuracy. However, there remains a lack of an appropriate panel of the most specific microRNA in the literature. The purpose of the present review was to summarize the existing data on the use of microRNAs as a diagnostic biomarker for venous thrombosis.

Keywords: biomarker; diagnosis; microRNA; prognosis; thromboembolism; thrombosis.

PubMed Disclaimer

References

REFERENCES

    1. Al-Homood, I. A. (2012). Thrombosis in systemic lupus erythematosus: A review article. ISRN Rheumatology, 2012, 428269. https://doi.org/10.5402/2012/428269
    1. Aird, W. C. (2007). Vascular bed-specific thrombosis. Journal of Thrombosis and Haemostasis, 5(Suppl 1), 283-291. https://doi.org/10.1111/j.1538-7836.2007.02515.x
    1. Arroyo, A. B., Ascensión, M., Teruel-Montoya, R., Vicente, V., González-Conejero, R., & Martínez, C. (2018). microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases? Thrombosis Research, 166, 1-9.
    1. Bates, S. M., Jaeschke, R., Stevens, S. M., Goodacre, S., Wells, P. S., Stevenson, M. D., … Guyatt, G. H. (2012). Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e351S-e418S. https://doi.org/10.1378/chest.11-2299
    1. Bazzan, M., Vaccarino, A., & Marletto, F. (2015). Systemic lupus erythematosus and thrombosis. Thrombosis Journal, 13, 16. https://doi.org/10.1186/s12959-015-0043-3

Publication types

LinkOut - more resources